Berry Genomics Co Ltd (000710) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.001x

Based on the latest financial reports, Berry Genomics Co Ltd (000710) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.18 Million ≈ $-319.41K USD) by net assets (CN¥1.65 Billion ≈ $241.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Berry Genomics Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Berry Genomics Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Berry Genomics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000710 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Berry Genomics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Berry Genomics Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Prince Housing & Development Corp
TW:2511
0.048x
Medistim ASA
OL:MEDI
0.098x
Genesco Inc
NYSE:GCO
0.314x
Jiangsu Huifeng Agrochemical Co Ltd
SHE:002496
0.002x
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
F:GU5
0.050x
Nouveau Monde Graphite Inc
NYSE:NMG
-0.133x
Trade-Van Information Services Co
TW:6183
0.038x
Heidelberger Druckmaschinen Aktiengesellschaft
F:HDD
-0.009x

Annual Cash Flow Conversion Efficiency for Berry Genomics Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Berry Genomics Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Berry Genomics Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.72 Billion
≈ $250.98 Million
CN¥87.97 Million
≈ $12.87 Million
0.051x -12.46%
2023-12-31 CN¥1.89 Billion
≈ $277.24 Million
CN¥111.01 Million
≈ $16.24 Million
0.059x +544.41%
2022-12-31 CN¥2.33 Billion
≈ $340.85 Million
CN¥21.18 Million
≈ $3.10 Million
0.009x -75.60%
2021-12-31 CN¥2.52 Billion
≈ $369.30 Million
CN¥94.03 Million
≈ $13.76 Million
0.037x -44.05%
2020-12-31 CN¥2.42 Billion
≈ $354.48 Million
CN¥161.31 Million
≈ $23.60 Million
0.067x +27.01%
2019-12-31 CN¥2.35 Billion
≈ $343.45 Million
CN¥123.06 Million
≈ $18.01 Million
0.052x -38.40%
2018-12-31 CN¥1.94 Billion
≈ $284.22 Million
CN¥165.33 Million
≈ $24.19 Million
0.085x +78.65%
2017-12-31 CN¥1.56 Billion
≈ $228.34 Million
CN¥74.35 Million
≈ $10.88 Million
0.048x +138.30%
2016-12-31 CN¥114.08 Million
≈ $16.69 Million
CN¥-14.19 Million
≈ $-2.08 Million
-0.124x +79.32%
2015-12-31 CN¥117.69 Million
≈ $17.22 Million
CN¥-70.81 Million
≈ $-10.36 Million
-0.602x -513.72%
2014-12-31 CN¥130.03 Million
≈ $19.03 Million
CN¥18.91 Million
≈ $2.77 Million
0.145x +12.60%
2013-12-31 CN¥121.00 Million
≈ $17.71 Million
CN¥15.63 Million
≈ $2.29 Million
0.129x -66.90%
2012-12-31 CN¥123.68 Million
≈ $18.10 Million
CN¥48.27 Million
≈ $7.06 Million
0.390x +322.78%
2011-12-31 CN¥122.50 Million
≈ $17.93 Million
CN¥-21.46 Million
≈ $-3.14 Million
-0.175x -128.10%
2010-12-31 CN¥122.22 Million
≈ $17.89 Million
CN¥76.19 Million
≈ $11.15 Million
0.623x +3165.21%
2009-12-31 CN¥114.51 Million
≈ $16.76 Million
CN¥-2.33 Million
≈ $-340.79K
-0.020x -103.67%
2008-12-31 CN¥104.34 Million
≈ $15.27 Million
CN¥57.76 Million
≈ $8.45 Million
0.554x +1012.22%
2007-12-31 CN¥94.51 Million
≈ $13.83 Million
CN¥4.70 Million
≈ $688.23K
0.050x -57.48%
2006-12-31 CN¥99.78 Million
≈ $14.60 Million
CN¥11.68 Million
≈ $1.71 Million
0.117x +52.21%
2005-12-31 CN¥98.59 Million
≈ $14.43 Million
CN¥7.58 Million
≈ $1.11 Million
0.077x +234.93%
2004-12-31 CN¥112.75 Million
≈ $16.50 Million
CN¥-6.43 Million
≈ $-940.18K
-0.057x -420.11%
2003-12-31 CN¥112.11 Million
≈ $16.41 Million
CN¥-1.23 Million
≈ $-179.74K
-0.011x -108.00%
2002-12-31 CN¥108.87 Million
≈ $15.93 Million
CN¥14.91 Million
≈ $2.18 Million
0.137x +125.90%
2001-12-31 CN¥161.48 Million
≈ $23.63 Million
CN¥-85.39 Million
≈ $-12.50 Million
-0.529x -1232.97%
2000-12-31 CN¥207.06 Million
≈ $30.30 Million
CN¥-8.21 Million
≈ $-1.20 Million
-0.040x -157.27%
1999-12-31 CN¥220.90 Million
≈ $32.33 Million
CN¥15.30 Million
≈ $2.24 Million
0.069x -48.25%
1998-12-31 CN¥211.44 Million
≈ $30.94 Million
CN¥28.30 Million
≈ $4.14 Million
0.134x --

About Berry Genomics Co Ltd

SHE:000710 China Diagnostics & Research
Market Cap
$434.54 Million
CN¥2.97 Billion CNY
Market Cap Rank
#12832 Global
#3741 in China
Share Price
CN¥8.40
Change (1 day)
-1.18%
52-Week Range
CN¥7.37 - CN¥16.61
All Time High
CN¥90.95
About

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcri… Read more